Kineta, Inc. (KA) 是一家上市公司 屬於 醫療保健 板塊，經營於 生物科技 產業. 公司總部位於 Seattle, WA, 美国. 現任CEO為 Craig W. Philips.
KA 擁有 IPO日期為 2016-02-11, 11 名全職員工, 在 NASDAQ Capital Marke, 市值為 $7.05M.
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
